Topics

A study in PLOS One suggests that the first few months of the COVID-19 pandemic saw increases in wine and spirit sales, accompanied by notable changes in the relationship between alcohol sales and people’s visits to businesses that sell alcohol.

Steven  J. Fliesler, PhD, has been awarded the University at Buffalo Graduate School’s 2021-2022 Distinguished Postdoc Mentor Award.

Students and laboratories affiliated with the Genetics, Genomics and Bioinformatics graduate program (GGB) shared their findings during the eighth annual GGB Research Day.

Two doctoral students in the Jacobs School of Medicine and Biomedical Sciences are among the recipients of the state’s second annual Graduate Research Empowering and Accelerating Talent (GREAT) awards.

Medical students with an interest in dermatology in the Jacobs School of Medicine and Biomedical Sciences have been coordinating community outreach events to spread educational and empowering messages.

A study led by senior author Paresh Dandona, MD, PhD, shows that bariatric surgery not only treats obesity and reverses Type 2 diabetes, it also reverses low testosterone levels in severely obese male teens.

Steven E. Lipshultz, MD, is senior author on a new study that shows healthier hearts in long-term childhood cancer survivors treated with a new drug, dexrazoxane, to protect their hearts from heart-damaging chemotherapy — even in those treated nearly 20 years ago.

A trainee in the doctoral program in biochemistry has been awarded a two-year predoctoral fellowship from the American Heart Association for her research on a fatal neurodegenerative disorder.

Gil I. Wolfe, MD, UB Distinguished Professor and the Irvin and Rosemary Smith Chair of neurology, has been appointed to the Food and Drug Administration (FDA) Cellular, Tissue and Gene Therapies Advisory Committee.

As the COVID-19 pandemic maintains its grip on the world, physicians at the Jacobs School of Medicine and Biomedical Sciences continue to step up in a myriad of ways to help the Western New York community.

Fifty-seven original research projects from aspiring physician-scientists were on display at the 2022 Medical Student Research Forum.

The start of the spring semester has come with questions about the need for a COVID-19 booster shot, which is strongly encouraged for UB employees and required by SUNY for students once medically eligible.

Mark D. Hicar, MD, PhD, associate professor of pediatrics in the Division of Infectious Diseases, has been awarded a $100,000 Microbial Pathogenesis in Alzheimer’s Disease Grant by the Infectious Diseases Society of America (IDSA) Foundation to explore a potential link between infectious diseases and Alzheimer’s disease.

Steven D. Schwaitzberg, MD, professor and chair of surgery, has partnered with Swiss medical education company VirtaMed to trial one of the company’s new mixed-reality laparoscopic simulators — the LaparoS. 

A student in UB’s summer research fellowship program, “Training the Next Generation of Physician-Scientists,” won the 2021 American Medical Association Research Challenge, emerging from more than 1,100 submissions to claim the grand prize of $10,000 in the largest national research competition among medical students, residents and fellows in the country.

A joint study between researchers at the University at Buffalo and UCLA demonstrates for the first time that a specific type of cognitive behavioral therapy (CBT) that teaches information processing skills can modulate key components of the brain-gut-microbiome axis in some of the most severe irritable bowel syndrome (IBS) patients.

The American College of Emergency Physicians (ACEP) has named seven Department of Emergency Medicine faculty members as 2021 New York ACEP Unsung Heroes for their dedicated clinical care.  

Researchers in the Department of Biomedical Engineering have successfully freeze-dried a liposome-based liquid vaccine formula that could be developed for potential use in COVID-19 vaccines.

A national study led by Jacobs School of Medicine and Biomedical Sciences emergency medicine physicians has found that patients with mild to moderate COVID-19 who are treated with an inhaled steroid are significantly less likely to require emergency department care or hospitalization due to COVID-19 than those treated with placebo.